The more important figure is completed enrollment date, certainly within 6 months after completed enrollment it is likely a push to buy into this.
What is real is assuming survival, speed of dilution is the elephant.
I have always with study taken exception to the lawsuit. I truly judged the company analyzed the previous phase 3 better than the FDA. A case of might makes right. Both the previous filters and the quality of the study were very 2nd rate, which was pre-Hobbs. Hatred to Hobbs and Simpson are pretty even, but different eras with different complaints.
News 
Market Data 
Discover 
